BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• FDA

  Amerigen Announces U.S. FDA Approval For Generic Penicillamine 250 mg Capsules

  The first generic version of Penicillamine Capsules USP is now approved in the U.S.

  May 8, 2019

   · 

  2 min read
• Biotech Beach

  Xencor to Present at Upcoming Investor Conferences - May 8, 2019

  Xencor, Inc. announced that company management will present at two upcoming conferences

  May 8, 2019

   · 

  1 min read
• Deals

  Perrigo To Divest Animal Health Business For $185 Million In Cash As Part Of Consumer Self-Care Transformation

  Perrigo Company plc, announced that it has reached a definitive agreement to sell its Animal Health business to PetIQ in a transaction valued at $185 million in cash.

  May 8, 2019

   · 

  5 min read
• Deals

  Transcat Announces Fourth Quarter and Full Fiscal Year 2019 Conference Call and Webcast

  Transcat, Inc. announced that it will release its fourth quarter and full fiscal year 2019 results after the close of financial markets on Tuesday, May 21, 2019.

  May 8, 2019

   · 

  2 min read
• Business

  SCYNEXIS Reports First Quarter 2019 Financial Results and Provides Company Update

  Continued advancement of VVC program, including completed favorable embryo-fetal safety profile, further supports a potential first NDA submission of oral ibrexafungerp in the second half of 2020

  May 8, 2019

   · 

  9 min read
• Business

  Nektar Therapeutics Reports Financial Results for the First Quarter of 2019

  Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the first quarter ended March 31, 2019.

  May 8, 2019

   · 

  14 min read
• Business

  Glaukos Corporation Announces First Quarter 2019 Financial Results

  Achieved 35% net sales growth to $54.0 million in the first quarter of 2019, compared to $40.1 million in the first quarter of 2018.

  May 8, 2019

   · 

  9 min read
• Drug Development

  Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical Trial of PRV-300 in Patients with Moderate-to-Severe Ulcerative Colitis

  Top-line results from its Phase 1b PULSE study which evaluated PRV-300, an anti-TLR3 monoclonal antibody, in patients with active, moderate-to-severe ulcerative colitis

  May 8, 2019

   · 

  4 min read
• BioMidwest

  Navidea Biopharmaceuticals Reports First Quarter 2019 Financial Results

  Conference Call to be held Wednesday, May 8, 2019 at 5:00 pm ET

  May 8, 2019

   · 

  8 min read
• Business

  Quidel Reports First Quarter 2019 Financial Results

  Announced today financial results for the first quarter ended March 31, 2019.

  May 8, 2019

   · 

  15 min read